3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
MicroPort Scientific's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 105.94%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for MicroPort Scientific's 3-Year ROIIC % or its related term are showing as below:
FRA:MSK's 3-Year ROIIC % is ranked better than 89.59% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs FRA:MSK: 105.94
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
MicroPort Scientific 3-Year ROIIC % Related Terms
MicroPort Scientific 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for MicroPort Scientific's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MSK vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, MicroPort Scientific's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort Scientific 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where MicroPort Scientific's 3-Year ROIIC % falls into.
MicroPort Scientific's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -46.618 (Dec. 2025) - -472.736 (Dec. 2022) )
/
( 2341.467 (Dec. 2025) - 2189.09 (Dec. 2022) )
=
426.118
/
152.377
=
279.65%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
MicroPort Scientific (FRA:MSK) has a 3-Year ROIIC % of 105.94 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MicroPort Scientific and its competitors. According to the industry distribution chart, MicroPort Scientific ranks #83 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 10.4%.
Is MicroPort Scientific's 3-Year ROIIC % too high?
MicroPort Scientific's current 3-Year ROIIC % is 105.94. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. MicroPort Scientific's value of 105.94 is 7106.8% above this industry median. Based on the distribution chart, MicroPort Scientific ranks #83 out of 797 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort Scientific has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MicroPort Scientific's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort Scientific ranks #83 out of 797 companies for 3-Year ROIIC %. This places MicroPort Scientific in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.47. MicroPort Scientific's value of 105.94 is 7106.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort Scientific's current 3-Year ROIIC % of 105.94 is 7106.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MicroPort Scientific and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort Scientific's current 3-Year ROIIC % is 105.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort Scientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort Scientific (FRA:MSK) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.98, compared to a current price of €0.75 — trading 23.5% below its estimated fair value. The current 3-Year ROIIC % is 105.94 and 7106.8% above the Medical Devices & Instruments industry median of 1.47. MicroPort Scientific's overall GF Score™ is 40/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For MicroPort Scientific (FRA:MSK), the current 3-Year ROIIC % is 105.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort Scientific (FRA:MSK) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort Scientific stock appears to be undervalued.
The current stock price of €0.75 is trading 23.5% below its estimated GF Value™ of €0.98.
GuruFocus considers MicroPort Scientific to be Modestly Undervalued.
Key valuation signals for FRA:MSK:
3-Year ROIIC %: 105.94
GF Value™: €0.98 vs. price of €0.75 (23.5% below fair value)
Industry Position: 7106.8% above the Medical Devices & Instruments median (#83 of 797)
No single metric tells the full story. See the FRA:MSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MSK has been successfully added to your 
